ACADIA Pharmaceuticals Inc. (ACAD)
-NasdaqGM 13.84 
0.31(2.19%) 1:11PM EDT - Nasdaq Real Time Price
| Prev Close: | 14.15 |
|---|
| Open: | 14.20 |
|---|
| Bid: | 13.91 x 600 |
|---|
| Ask: | 13.93 x 400 |
|---|
| 1y Target Est: | 17.25 |
|---|
| Beta: | 3.32 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 13.50 - 14.55 |
|---|
| 52wk Range: | 1.30 - 14.75 |
|---|
| Volume: | 2,366,708 |
|---|
| Avg Vol (3m): | 3,868,310 |
|---|
| Market Cap: | 1.10B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.34 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)at TheStreet(Tue 10:38AM EDT)
- ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common StockBusiness Wire(Mon, May 20)
- ACADIA Pharmaceuticals Added to NASDAQ Biotechnology IndexBusiness Wire(Mon, May 20)
- Too Many Questions Make This Thursday Mover a Sellat Motley Fool(Mon, May 20)
- 5 of Last Week's Biggest Winnersat Motley Fool(Sun, May 19)
- ACADIA Pharma Floats New Stock Issueat Motley Fool(Wed, May 15)
- ACADIA Prices Public Offering and 2 Other Hot Stocks to Watchat Wall St. Cheat Sheet(Wed, May 15)
- ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Wed, May 15)
- This Stock Should Get Better in the Long Runat Motley Fool(Wed, May 15)
- 2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Playat Seeking Alpha(Wed, May 15)
- ACADIA Pharmaceuticals Prices Public Offering of Common StockBusiness Wire(Wed, May 15)
- ACADIA Pharmaceuticals Announces Proposed Public Offering of Common StockBusiness Wire(Tue, May 14)
- Acadia rises as analyst considers sale possibilityAP(Mon, May 13)
- ACADIA PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Sat, May 11)
- Faruqi & Faruqi, LLP Launches An Investigation Against ACADIA Pharmaceuticals Inc. (ACAD) For Potential Breaches Of Fiduciary Duties By Its Board Of DirectorsBusiness Wire(Fri, May 10)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 229.83 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.38 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.09 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | -1.70 |
|---|
Business Summary
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
View More